Your browser doesn't support javascript.
loading
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh, Milad; Saebfar, Hamidreza; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Zabolian, Amirhossein; Bikarannejad, Pooria; Hashemi, Mehrdad; Daneshi, Salman; Mirzaei, Sepideh; Sharifi, Esmaeel; Kumar, Alan Prem; Khan, Haroon; Heydari Sheikh Hossein, Hamid; Vosough, Massoud; Rabiee, Navid; Kumar Thakur, Vijay; Makvandi, Pooyan; Mishra, Yogendra Kumar; Tay, Franklin R; Wang, Yuzhuo; Zarrabi, Ali; Orive, Gorka; Mostafavi, Ebrahim.
Afiliação
  • Ashrafizadeh M; Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanli, Tuzla, 34956 Istanbul, Turkey.
  • Saebfar H; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Gholami MH; DVM. Graduated, Faculty of Veterinary Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran.
  • Hushmandi K; Department of Food Hygiene and Quality Control, Division of epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Zabolian A; Department of Orthopedics, School of Medicine, 5th Azar Hospital, Golestan University of Medical Sciences, Golestan, Iran.
  • Bikarannejad P; Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Hashemi M; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Daneshi S; Department of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.
  • Mirzaei S; Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.
  • Sharifi E; Department of Tissue Engineering and Biomaterials, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, 6517838736 Hamadan, Iran.
  • Kumar AP; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Khan H; Cancer Science Institute of Singapore and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Heydari Sheikh Hossein H; Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan.
  • Vosough M; Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
  • Rabiee N; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Kumar Thakur V; Department of Chemistry, Sharif University of Technology, Tehran, Iran.
  • Makvandi P; School of Engineering, Macquarie University, Sydney, New South Wales, Australia.
  • Mishra YK; Biorefining and Advanced Materials Research Center, Scotland's Rural College (SRUC), Kings Buildings, West Mains Road, Edinburgh EH9 3JG, U.K.
  • Tay FR; School of Engineering, University of Petroleum & Energy Studies (UPES), Dehradun 248007, Uttarakhand, India.
  • Wang Y; Istituto Italiano di Tecnologia, Centre for Materials Interfaces, viale Rinaldo Piaggio 34, Pontedera, Pisa, 56025 Italy.
  • Zarrabi A; Mads Clausen Institute, NanoSYD, University of Southern Denmark, 6400 Sønderborg, Denmark.
  • Orive G; The Graduate School, Augusta University, Augusta, GA, USA.
  • Mostafavi E; Department of Urological Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Expert Opin Drug Deliv ; 19(4): 355-382, 2022 04.
Article em En | MEDLINE | ID: mdl-35152815

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanocompostos / Nanopartículas / Nanopartículas Metálicas / Grafite / Neoplasias Limite: Humans Idioma: En Revista: Expert Opin Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanocompostos / Nanopartículas / Nanopartículas Metálicas / Grafite / Neoplasias Limite: Humans Idioma: En Revista: Expert Opin Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Reino Unido